Instrument Development of Screening Prediabetes Patients

Prediabetic State Clinical Trial

Official title:

Instrument Development of Screening Prediabetes Patients

Clinical Trial Details — Status: Terminated

Administrative data

• NCT number: NCT00308646
• Other study ID #: NSC93-2314-B-039-025
• Status: Terminated
• Phase: N/A
• First received: March 29, 2006
• Last updated: March 29, 2006
• Start date: October 2004
• Est. completion date: July 2005

Study information

• Verified date: March 2006
• Source: China Medical University Hospital
• Contact: n/a
• Is FDA regulated: No
• Health authority: Taiwan: Department of Health
• Study type: Observational

Clinical Trial Summary

It will be more effective if we can work on the primary prevention for the high risk groups of diabetes and prediabetes such as the early detection.

Description:

During the past years, many efforts were put on the diagnosis and treatment of DM and its complications. It will be more effective if we can work on the primary prevention for the high risk groups of diabetes and prediabetes such as the early detection. As a first public health step, it is worthwhile to identify prediabetes people in community by screening program. Three thousand persons will be randomly selected from residents of Taichung city. All the participants will fulfill a structured questionnaire and 'Diabetes risk factor screening tool' which American Diabetes Association suggested in 2003. This project will estimate the prevalence of prediabetes in conventional hospital-base population as well as the validity of a screening questionnaire for prediabetes.

Recruitment information / eligibility

• Status: Terminated
• Enrollment: 3000
• Est. completion date: July 2005
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 40 Years and older

Eligibility

Inclusion Criteria:

Residents aged 40 and over of Taichung city, Taiwan in October, 2004.

Exclusion Criteria:

Study Design

Allocation: Random Sample, Primary Purpose: Screening, Time Perspective: Cross-Sectional

Related Conditions & MeSH terms

• Prediabetic State

Locations

Country	Name	City	State
n/a

Sponsors (2)

Lead Sponsor	Collaborator
China Medical University Hospital	National Science Council, Taiwan